In this episode of Denatured, Lori and guests from Teva Pharmaceuticals and TOWER Capital discuss the opportunties, regulatory challenges and uncertainty surrounding AI.
Abstract: Some have suggested that the refolding of denatured aminoacylase is difficult. The present study reports that aminoacylase denatured in urea concentrations more than 4 mol/L was markedly but ...
In this episode, we’re talking money. The guests in this discussion recognize that the economic climate has been different (and more chaotic) in last three to four months, but expect a steady but slow ...